Grand network convergence by Bader, Joel S
The success of the human genome project has provided a 
model for an analogous interactome project to map how 
proteins, genes, metabolites and other regulatory compo­
nents  interact  to  transform  a  biochemical  soup  into  a 
living system. These maps promise to serve as a frame­
work  for  models  that  predict  how  a  biological  system 
responds to a perturbation or an input, which is relevant 
to gene mutations and therapeutic treatment in human 
disease, and as a framework for designing new systems in 
synthetic biology.
Three  major  themes  arose  during  the  2011  meeting: 
technological  drivers  and  data  generation,  algorithmic 
advances,  and  convergence  on  biological  applications 
with context­sensitive networks.
Technological drivers and data generation
Many  recent  biomedical  advances  are  being  driven  by 
technological  advances.  Advances  in  DNA  sequencing 
technology are paralleled by advances in network map­
ping  technologies,  although  network  mapping  may  be 
more  complicated  because  the  biochemical  species 
(proteins,  metabolites,  RNA  and  small  molecules)  are 
diverse compared with genome sequencing (DNA only). 
Although knowledge of networks is far from complete, 
the numbers of unknown interactions are moving from 
‘unknown unknowns’ to ‘known unknowns’.
Physical interactions continue to be of great interest. 
Protein­protein binding interactions are being systemati­
cally  mapped  using  mass  spectrometry  of  protein 
complex  components  (Anne­Claude  Gavin,  EMBL, 
Heidel  berg, Germany), and they are continuing to reveal 
interactions not anticipated by any existing data. In an 
advance  that  could  revolutionize  the  yeast  two­hybrid 
system, next­generation sequencing is being incorporated 
as  the  back­end  read­out  (Pascal  Braun,  Dana  Farber 
Cancer  Institute,  Harvard  University,  USA).  Steady 
advances over the past several years have developed the 
two­hybrid system to the point that the false­positive rate 
is  very  low,  with  precision  of  high­throughput  screens 
roughly  equivalent  to  careful,  small­scale  studies.  The 
significance of the next­generation sequencing applica­
tion is that the coverage or true­positive rate, which in 
previous  work  has  been  low,  could  conceivably  be  in­
creased to approach moderate to near full coverage of 
interactions  amenable  to  two­hybrid  assays.  Enhanced 
yeast  one­hybrid  systems  are  also  providing  increased 
coverage of regulatory interactions between transcription 
factors and DNA (Marian Walhout, University of Massa­
chusetts Medical School, USA).
New technologies are opening up the ability to probe 
unexplored types of interactions. Lipids and interactions 
between membrane­localized proteins have been difficult 
to  study  using  traditional  methods.  New  protein­lipid 
binding assays are becoming available for medium­scale 
applications  (Gavin).  Cell  signaling  networks  are  being 
mapped using membrane two­hybrid technologies (Igor 
Stagljar, University of Toronto, Canada).
Microarray  technologies  continue  to  be  adapted  to 
mapping  biological  interactions.  Interactions  between 
trans  cription  factors  and  DNA  using  universal  DNA 
probes have become highly reliable. Much like protein 
structure  pipelines  that  have  increasingly  focused  on 
discovering novel folds, protein­DNA binding assays are 
being focused on the transcription factors that are most 
likely  to  have  novel  binding  motifs  that  cannot  yet  be 
predicted by homology (Timothy Hughes, University of 
Toronto, Canada). Microarrays of spotted proteins provide 
continuing  opportunities  for  novel  functional  screens, 
such  as  mapping  kinase­substrate  interactions  at  the 
genome scale (Heng Zhu, Johns Hopkins University, USA).
A final theme of new technologies is a push to measur­
ing interactions and activities in living systems. A recent 
single­cell  mass  cytometry  technology  allows  simul­
taneous  measurement  of  about  30  parameters  about  a 
cell,  including  surface  and  functional  markers  (Gary 
Nolan,  Stanford  University,  USA).  The  resulting  data 
provide  a  dynamic  view  of  cell  development  and  an 
indication of drug activity.
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A  growing  number  of  statistical  methods  use  network 
data to link a biological input to an output (phenotype). 
In linear systems, given two out of three of input, system 
(transfer function) and output, we can reproduce what is 
missing. Being able to do the same for biological systems 
would  have  great  utility  in  predicting  disease  risk, 
developing new therapeutics, and so on. Biology is more 
complicated because inputs and outputs are ill­specified, 
and knowledge of the system (network) is poor. Never­
theless, network data are sufficiently complete that they 
are proving useful in linking biological inputs and outputs.
An  important  new  direction  in  algorithmic  develop­
ment  is  the  integration  of  multiple  data  sources  to 
provide  a  fuller  picture  of  cellular  activity.  This  is 
especially  important  in  studying  multiscale  processes, 
such  as  animal  development,  in  which  protein­level 
interactions translate to patterns visible by eye. Imaging 
data are now being harnessed to improve the inference of 
developmental  regulatory  pathways,  with  predictions 
validated by mutant studies (Nicholas Luscombe, EMBL 
European Bioinformatics Institute, UK).
Even single­cell dynamic processes have been difficult 
to  study  because  technologies  that  measure  networks 
typically  provide  a  static  picture,  requiring  additional 
dynamic  measurements  to  understand  how  network 
compo  nents change and networks reorganize over time. I 
described  new  methods  for  coupling  interaction  net­
works with transcription time series to provide a moving 
picture of network activity.
Data integration methods provide improved ability to 
predict  disease  outcomes  (Kelvin  Zhang,  University  of 
California, Los Angeles, USA, and Ontario Institute for 
Cancer Research, Canada), predict gene function (Quaid 
Morris, University of Toronto, Canada), and map regula­
tory  networks  (Sushmita  Roy,  Broad  Institute,  USA). 
Combining  data  from  genetic  interactions,  physical 
interactions  and  protein  sequence  provides  a  more 
accurate  picture  of  how  networks  have  evolved  (Amy 
Keating,  Massachusetts  Institute  of  Technology,  USA, 
and Chad Myers, University of Minnesota, USA).
Network­based  algorithms  can  assist  in  generating 
hypotheses about how a gene mutation leads to disease 
(Theresa  Przytycka,  National  Institutes  of  Health, 
Bethesda, USA, and Patrick Aloy, Institute for Research 
in  Biomedicine,  Spain).  Metabolic  models  have  been 
developed that can link biochemical measurements, such 
as  metabolite  uptake,  to  growth  rate  (Zoltan  Oltvai, 
University of Pittsburgh, USA).
Convergence on biological applications
Cells  can  have  identical  DNA  but  be  very  different 
because  they  express  different  genes.  These  different 
contexts  imply  the  existence  of  different  network 
compo  nents  (proteins  in  signal  transduction  or  gene 
regulation,  microRNAs,  metabolites,  lipids  and  small 
molecules)  and  different  network  states.  Networks  are 
usually not measured for a specific context, however, but 
rather  through  biochemical  assays  (protein­binding 
micro  arrays,  and  yeast  one­hybrid  and  two­hybrid 
systems) or by superimposing data from many distinct 
conditions  (chromatin  immunoprecipitation  with 
microarrays (ChIP­chip) and with sequencing (ChIP­seq), 
epistatic  inter  actions,  condition­specific  pull­downs,  or 
time series). Several groups presented work showing how 
network  state  can  be  inferred  by  integrating 
heterogeneous datasets and how differences in network 
state correspond to differences in phenotype.
Recent work has demonstrated that network contrasts, 
defined as differences in interaction patterns measured in 
different conditions, can be more informative of bio  logi  cal 
processes than interactions measured in individual states. 
Contrasts  can  be  generated  through  several  types  of 
perturbations.  Yeast  genetic  interaction  screens  have 
used  small­molecule  treatments  to  generate  contrasts 
(Trey Ideker, University of California, San Diego, USA). 
Contrastive analysis in cell signaling using a combination 
of  genetics  and  small  molecules  provides  insight  into 
pathways relevant to leukemia (Thomas Graeber, Univer­
sity  of  California,  Los  Angeles,  USA).  Host­patho  gen 
networks can be probed as a function of the pathogen 
genotype; studies of human papilloma virus showed that 
high­risk  and  low­risk  strains  had  interactions  with 
different  subsets  of  human  host  proteins  (David  Hill, 
Dana­Farber Cancer Institute, Harvard University, USA).
These observations may be valuable in human health, 
for example by identifying patient­specific differences in 
network state (Anna Goldenberg, University of Toronto, 
Canada).  An  intriguing  possibility  is  that  some  of  the 
heterogeneity in network state may not be genetic but 
rather purely stochastic (Suzanne Gaudet, Dana­Farber 
Cancer Institute, Harvard University, USA).
Beyond observing network activity is the challenge of 
shaping  network  state.  Future  drug  treatments  may 
involve perturbing a network to control the response to 
drug treatment (Michael Yaffe, Massachusetts Institute of 
Technology, USA), or using computational techniques to 
identify  key  components  of  disease  pathways  (Andrea 
Califano, Columbia University, USA). Finally, new synthetic 
biology  technologies  are  providing  an  entirely  new 
capability to rebuild biological systems from the DNA up, 
with exciting applications to human health and bioenergy 
(James Collins, Wyss Institute, Boston University, USA).
Networks are providing a clearer picture of the struc­
ture of biological systems. Individual datasets, focused on 
distinct types of interactions, are sufficiently complete to 
provide a coherent, though not yet seamless, framework 
of cellular behavior, from ligand­receptor interactions to 
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networks are often described as ‘wiring diagrams’ , in reality 
the ability to predict the behavior of a biological system or 
to design a new system remains at the cusp of systems 
biology  research.  Transforming  network  maps  to  func­
tional models is the crucial challenge for systems biology.
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